Sex difference in anti‐sperm antibodies

Abstract Background Some diseases have sex differences. There have been no reports on the relationship between anti‐sperm antibodies (ASA) and sex differences. Methods ASA are detected by sperm‐immobilization test using patients' sera in women. In men, the ASA testing is generally performed by...

Full description

Bibliographic Details
Main Authors: Hiroaki Shibahara, Yuekun Chen, Haruka Honda, Yu Wakimoto, Atsushi Fukui, Akiko Hasegawa
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Reproductive Medicine and Biology
Subjects:
Online Access:https://doi.org/10.1002/rmb2.12477
_version_ 1797976009829515264
author Hiroaki Shibahara
Yuekun Chen
Haruka Honda
Yu Wakimoto
Atsushi Fukui
Akiko Hasegawa
author_facet Hiroaki Shibahara
Yuekun Chen
Haruka Honda
Yu Wakimoto
Atsushi Fukui
Akiko Hasegawa
author_sort Hiroaki Shibahara
collection DOAJ
description Abstract Background Some diseases have sex differences. There have been no reports on the relationship between anti‐sperm antibodies (ASA) and sex differences. Methods ASA are detected by sperm‐immobilization test using patients' sera in women. In men, the ASA testing is generally performed by direct‐immunobead test. Main findings Sperm‐immobilizing antibodies in women inhibit sperm migration in their genital tract and exert inhibitory effects on fertilization. ASA bound to sperm surface in men also show inhibitory effect on sperm passage through cervical mucus. The fertilization rate of IVF significantly decreased when sperm were coated with higher numbers of ASA. For women with the antibodies, it is important to assess individual patients' SI50 titers. In patients with continuously high SI50 titers, pregnancy can be obtained only by IVF. For men with abnormal fertilizing ability by ASA, it is necessary to select intracytoplasmic sperm injection. Production of sperm‐immobilizing antibodies is likely to occur in women with particular HLA after exposure to sperm. The risk factors for ASA production in men are still controversial. Conclusion Attention to sex differences in specimens, test methods and the diagnosis of ASA should be paid. For patients with ASA, treatment strategies have been established by considering sex difference for each.
first_indexed 2024-04-11T04:44:30Z
format Article
id doaj.art-64a795f36f3e440eb8469e4c98a8cb3c
institution Directory Open Access Journal
issn 1445-5781
1447-0578
language English
last_indexed 2024-04-11T04:44:30Z
publishDate 2022-01-01
publisher Wiley
record_format Article
series Reproductive Medicine and Biology
spelling doaj.art-64a795f36f3e440eb8469e4c98a8cb3c2022-12-27T13:54:58ZengWileyReproductive Medicine and Biology1445-57811447-05782022-01-01211n/an/a10.1002/rmb2.12477Sex difference in anti‐sperm antibodiesHiroaki Shibahara0Yuekun Chen1Haruka Honda2Yu Wakimoto3Atsushi Fukui4Akiko Hasegawa5Department of Obstetrics and Gynecology School of Medicine, Hyogo Medical University Nishinomiya JapanDepartment of Obstetrics and Gynecology School of Medicine, Hyogo Medical University Nishinomiya JapanDepartment of Obstetrics and Gynecology School of Medicine, Hyogo Medical University Nishinomiya JapanDepartment of Obstetrics and Gynecology School of Medicine, Hyogo Medical University Nishinomiya JapanDepartment of Obstetrics and Gynecology School of Medicine, Hyogo Medical University Nishinomiya JapanDepartment of Obstetrics and Gynecology School of Medicine, Hyogo Medical University Nishinomiya JapanAbstract Background Some diseases have sex differences. There have been no reports on the relationship between anti‐sperm antibodies (ASA) and sex differences. Methods ASA are detected by sperm‐immobilization test using patients' sera in women. In men, the ASA testing is generally performed by direct‐immunobead test. Main findings Sperm‐immobilizing antibodies in women inhibit sperm migration in their genital tract and exert inhibitory effects on fertilization. ASA bound to sperm surface in men also show inhibitory effect on sperm passage through cervical mucus. The fertilization rate of IVF significantly decreased when sperm were coated with higher numbers of ASA. For women with the antibodies, it is important to assess individual patients' SI50 titers. In patients with continuously high SI50 titers, pregnancy can be obtained only by IVF. For men with abnormal fertilizing ability by ASA, it is necessary to select intracytoplasmic sperm injection. Production of sperm‐immobilizing antibodies is likely to occur in women with particular HLA after exposure to sperm. The risk factors for ASA production in men are still controversial. Conclusion Attention to sex differences in specimens, test methods and the diagnosis of ASA should be paid. For patients with ASA, treatment strategies have been established by considering sex difference for each.https://doi.org/10.1002/rmb2.12477anti‐sperm antibodyautoimmune diseasesex differencesperm‐immobilizing antibody
spellingShingle Hiroaki Shibahara
Yuekun Chen
Haruka Honda
Yu Wakimoto
Atsushi Fukui
Akiko Hasegawa
Sex difference in anti‐sperm antibodies
Reproductive Medicine and Biology
anti‐sperm antibody
autoimmune disease
sex difference
sperm‐immobilizing antibody
title Sex difference in anti‐sperm antibodies
title_full Sex difference in anti‐sperm antibodies
title_fullStr Sex difference in anti‐sperm antibodies
title_full_unstemmed Sex difference in anti‐sperm antibodies
title_short Sex difference in anti‐sperm antibodies
title_sort sex difference in anti sperm antibodies
topic anti‐sperm antibody
autoimmune disease
sex difference
sperm‐immobilizing antibody
url https://doi.org/10.1002/rmb2.12477
work_keys_str_mv AT hiroakishibahara sexdifferenceinantispermantibodies
AT yuekunchen sexdifferenceinantispermantibodies
AT harukahonda sexdifferenceinantispermantibodies
AT yuwakimoto sexdifferenceinantispermantibodies
AT atsushifukui sexdifferenceinantispermantibodies
AT akikohasegawa sexdifferenceinantispermantibodies